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ABSTRACT
RNA decay is usually mediated by protein
complexes and can occur in specific foci such as
P-bodies in the cytoplasm of eukaryotes. In human
mitochondria nothing is known about the spatial or-
ganization of the RNA decay machinery, and the
ribonuclease responsible for RNA degradation has
not been identified. We demonstrate that silencing
of human polynucleotide phosphorylase (PNPase)
causes accumulation of RNA decay intermediates
and increases the half-life of mitochondrial
transcripts. A combination of fluorescence lifetime
imaging microscopy with Fo¨rster resonance energy
transfer and bimolecular fluorescence complemen-
tation (BiFC) experiments prove that PNPase and
hSuv3 helicase (Suv3, hSuv3p and SUPV3L1) form
the RNA-degrading complex in vivo in human
mitochondria. This complex, referred to as the
degradosome, is formed only in specific foci
(named D-foci), which co-localize with mitochon-
drial RNA and nucleoids. Notably, interaction
between PNPase and hSuv3 is essential for efficient
mitochondrial RNA degradation. This provides
indirect evidence that degradosome-dependent
mitochondrial RNA decay takes place in foci.
INTRODUCTION
RNA turnover plays a fundamental role in the regulation
of gene expression, and it is mediated by protein
complexes, such as the bacterial degradosome, the yeast
mitochondrial degradosome or the eukaryotic nuclear or
cytosolic exosomes (1–4). Moreover, RNA degradation is
often spatially organized. For example, in the cytoplasm
of eukaryotic cells, distinct foci called P-bodies are
involved in RNA turnover (5). In human mitochondria,
the enzyme responsible for RNA degradation has not been
identified so far, and nothing is known about spatial or-
ganization of the RNA decay machinery.
Human mitochondrial DNA (mtDNA) is a circular
double-stranded DNA molecule, which is organized into
mitochondrial nucleoids containing mtDNA together with
proteins involved in its metabolism (6,7). The genome
contains 37 genes coding for 13 proteins, two ribosomal
RNAs (rRNAs) and a set of 22 transfer RNAs (tRNAs),
which generally flank other genes. During expression of
mitochondrial genetic information, both strands of
mtDNA (H-heavy and L-light) are transcribed into long
polycistronic transcripts, which are processed by
endoribonucleases acting at tRNA sequences (8–11).
Such processing results in the formation of mature mes-
senger RNAs (mRNAs), rRNAs, tRNAs and large
amounts of non-coding RNA complementary to
mRNAs and rRNAs, which are immediately removed
(12). Thus, RNA decay is not only involved in the regu-
lation of gene expression by regulating the levels of func-
tional RNAs but also, in addition, is necessary for
degradation of RNA-processing by-products and
removal of potentially toxic malformed RNA molecules.
Therefore, the identification of the enzyme responsible for
mitochondrial RNA (mtRNA) decay is essential for
understanding the aforementioned processes in human
mitochondria.
In Saccharomyces cerevisiae, mtRNA decay is per-
formed by a two-subunit complex called the mitochon-
drial degradosome, which consists of RNA helicase Suv3
and hydrolytic exoribonuclease Dss1 (13–16).
In contrast to yeast, plant mtRNA is degraded by
polynucleotide phosphorylase (PNPase) (17). PNPase
catalyzes processive 30 to 50 phosphorolysis of RNA and
the reverse reaction, in which nucleoside diphosphates
serve as substrates for elongation of the 30 end of RNA
(18). Plant mitochondrial PNPase takes part in degrad-
ation of rRNA and tRNA-processing intermediates,
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non-coding RNA transcribed from intergenic regions and
antisense RNA (17).
Human PNPase was initially identified as a gene up-
regulated in terminal cellular differentiation and senes-
cence (19), and it was found to localize to mitochondria
(20). In Escherichia coli, PNPase is a component of the
degradosome, the complex responsible for degradation of
polyadenylated RNAs, which consists of PNPase,
ribonuclease (RNase) E, the RhlB helicase and the glyco-
lytic enzyme enolase (21). Bacterial PNPase forms a
homotrimeric complex with a ring-like structure surround-
ing the central channel through which single-stranded
RNA is threaded (22,23). Similarly, human PNPase was
found to exist as a homotrimer (24).
Mammalian mtRNA stability factors are largely
undefined. The best known one is the LRPPRC–SLIRP
complex (25–27). However, none of its components have
enzymatic activity required for RNA degradation. So far,
the human ortholog of yeast Suv3 helicase (hSuv3) is the
only enzyme that has been shown to be directly involved
in mtRNA decay. Silencing of hSUV3 expression or
induction of an exogenous hSuv3G207V dominant-negative
mutant in human cells results in increased stability of
mature mRNAs and the accumulation of RNA species
not observed under normal conditions because of their
rapid removal or low abundance, i.e. mtRNA decay
intermediates, aberrantly formed RNAs, processing by-
products and vast amounts of non-coding antisense
RNA (28).
In contrast to the well-documented involvement of
hSuv3 helicase in mtRNA degradation, the identity of
its ribonucleolytic partner is still unknown. As there is
no human ortholog of the yeast Dss1 RNase, we con-
sidered PNPase as potential interactor of hSuv3. We
have reported co-purification of both proteins from
human mitochondria (28). On the other hand, PNPase
was shown to be present in the mitochondrial inter-
membrane space (IMS) (29), where it functions in RNA
import into mitochondria (30). Moreover, silencing of
PNPase led to conflicting results, not necessarily suggest-
ing the involvement of this enzyme in mtRNA metabolism
(29,31,32).
Here, we show that human mtRNA degradation is
mediated by a PNPase–hSuv3 complex that occurs in
distinct foci. We demonstrate that silencing of PNPase
has a similar effect on accumulation of undegraded
RNA decay intermediates as does dysfunction of hSuv3
(28). We present data that prove the in vivo interaction of
PNPase and hSuv3. Notably, formation of the complex is
necessary for mtRNA degradation. Our results indicate
that the RNase PNPase and the helicase hSuv3 together
form the human mitochondrial degradosome.
MATERIALS AND METHODS
Cell culture and siRNA transfection
HeLa, 143B or 293 T-Rex cells (Invitrogen) were grown as
a monolayer at 37C, under 5% CO2 in DMEM medium
(Gibco) supplemented with 10% FBS (Gibco) or TET
System Approved FBS (Clontech) in case of stable
inducible cell lines. Silencing of PNPase gene was
performed using stealthRNA and Lipofectamine
RNAiMAX according to the manufacturer’s instructions
(Invitrogen). The stealthRNA oligo ID HSS131758
(named si1), HSS131759 (si2) and negative control
(StealthTM RNAi Negative Control Med GC) were used
at a Enal concentration of 20 nM. Cells were plated 2 days
after transfection and collected after 2 additional days of
culturing. Expression of exogenous genes was induced by
addition of tetracycline to the culture medium at a
concentration of 25 ng/ml.
DNA cloning and establishment of stably
transfected cell lines
DNA cloning was performed using standard procedures
and described in Supplementary Data together with the
establishment of stable cell lines. All constructs are listed
in Supplementary Table S1.
Western blotting
Protein samples were prepared and processed as described
previously (28). Used antibodies are listed in
Supplementary Data.
Northern blot analysis
Total RNA was isolated by TRI Reagent (Sigma) using
the manufacturer’s protocol and analyzed essentially, as
described previously (28). For details see Supplementary
Data.
RNA half-life calculation
Newly transcribed RNA in cells treated with stealthRNA
(specific for PNPase gene or negative control) was meta-
bolically labeled by culturing cells for 1 h in the presence
of 250 mM 4-thiouridine (4sU) (Sigma). Total RNA was
isolated by TRI Reagent (Sigma); 100 mg of RNA was
biotinylated in RNase free Biotinylation Buffer (10mM
Tris, pH 7.4) for 1.5 h with rotation; 2 mg of biotin
(EZ-Link Biotin-HPDP, Catalog No. 21341) per 1 mg of
RNA was used. RNA was extracted by chloroform/
isoamyl alcohol (24:1) and precipitated with 0.5M NaCl
and isopropanol. After dissolving in water, the RNA was
heated to 65C for 10 min, then placed on ice for 5min
and incubated with streptavidin-coupled DynabeadsTM
(Invitrogen) for 15min with rotation at room tempera-
ture, as described in Dolken et al. (33). Beads were
separated from solution using a magnet stand; solution
containing unbound RNA was stored at 80C (un-
labeled fraction—pre-existing RNA). Beads were washed
three times with washing buffer (100mM Tris, pH 7.5;
10mM EDTA; 1M NaCl and 0.1% Tween20) heated to
65C and three times with the same buffer at room tem-
perature. RNA bound to beads (labeled fraction—newly
synthesized RNA) was eluted from beads with 100mM
dithiothreitol in RNase-free water and recovered with
RNeasy mini columns (Qiagen) according to the manu-
facturer’s instructions and stored in 80C. A total
of 1.5–2mg of RNA was dissolved in denaturing solu-
tion and run on a 1% agarose gel, as described
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previously (28). For quantification of pre-existing and
total RNA amount, northern blot analysis was per-
formed with riboprobes specific for transcripts: ND2,
ND3, CytB, COX2, mirror-COX1 (labeled with [a-32P]
UTP on the template of a polymerase chain reaction
[PCR] products listed in Supplementary Information).
For standardization, filters were re-probed with a 7SL
probe (28). Autoradiograms were collected, and signal
intensity was counted by Multi Gauge V3.0 software
(FujiFilm). RNA half-life calculations were based on
the ratio of pre-existing RNA to total RNA, as described
in (33). To obtain the final ratios, we applied in
the equation the correction factor described by Dolken
et al. (33).
Protein purification
Mitochondria were isolated as described previously (28).
The following procedure was performed at 4C. Just
before lysis, mitochondria isolated from cells expressing
PNPase-FLAG were mixed with mitochondria from cells
expressing hSuv3-TAP in the ratio of 1:3. This ratio was
chosen because of the higher expression of PNPase-FLAG
in comparison with endogenous PNPase. Mitochondrial
extracts were cleared by centrifugation, mixed with IgG
Sepharose (GE Healthcare) and incubated for 1.5 h with
rotation. If indicated, RNase A was added at this step to
obtain a final concentration of 40 mg/ml. After incubation,
resins were extensively washed with IPP 150 buffer and
TEV cleavage buffer. Proteins were eluted by treatment
with TEV protease for 2 h at 18C. Collected eluates were
analyzed by western blotting.
Fluorescence lifetime imaging microscopy-Fo¨rster
resonance energy transfer (FLIM-FRET) and bimolecular
fluorescence complementation (BiFC) analysis
HeLa cells analyzed by fluorescence lifetime imaging
microscopy-Fo¨rster resonance energy transfer (FLIM-
FRET) were grown on Lab-TekTM II Chamber SlidesTM
(Nunc). Cells were transiently transfected using the
TransIT LT2020 reagent (Mirus) according to the manu-
facturer’s instructions. A total of 50 ng of each DNA con-
struct and 7000 cells were used per transfection. Following
24 h of incubation, cells were imaged with a FluoView1000
confocal microscope (Olympus) with a Compact Lifetime
and FCS Upgrade Kit (PicoQuant) on an inverted IX81
microscope, using a PLANAPO 60.0 1.40 oil objective.
PNPase-EGFP fusion protein was excited by a 483-nm
pulsing laser. Image analysis was performed with the
SymphoTime software (PicoQuant). For bimolecular
fluorescence complementation (BiFC) analysis, HeLa
cells were plated in six-well plates to get a confluence of
40–50% at the time of transfection. Cells were transfected
with 500 ng of each DNA construct (pRS407/pRS412,
pRS408/pRS412, pRS409/pRS411 and pRS410/pRS411)
with usage of TransIT LT2020 reagent (Mirus).
Twenty-four hours later, cells were passaged to
Lab-TekTM II Chamber SlidesTM (Nunc) and analyzed
for the following additional 24 h. Before imaging cells,
mitochondria were labeled with MitoTracker Orange
CMTM-Ros (0.1 mM) (Molecular Probes) and analyzed
using a FluoView1000 confocal microscope (Olympus)
with a PLANAPO 60.0 1.40 oil objective. The 3D recon-
structions were done using Imaris 7.2.3 software
(Bitplane).
Immunofluorescence
HeLa or 143B cells were plated on glass cover slips for
24 h, then transfected with BiFC DNA constructs using
the TransIT LT2020 reagent (Mirus). After 1 day of
culturing, cells were fixed with 4% formaldehyde and sub-
jected to the immunostaining procedure described previ-
ously (28). If needed, RNA was labeled by the addition of
bromouridine (BrU) (2.5mM) (Sigma) to the culture
medium 20min before fixation. Mitochondria were
stained by addition of MitoTracker DeepRed (0.25 mM)
(Molecular Probes) to the culture medium 20min before
fixation. PNPase-C-Venus was detected with goat poly-
clonal anti-GFP antibodies (I-16, sc-5385, Santa Cruz);
RNA was detected with rat monoclonal anti-BrdU
antibodies (ab6326, Abcam) and DNA was stained with
anti-DNA mouse monoclonal IgM antibodies (ProGen).
Suitable secondary antibodies conjugated with Alexa488,
Alexa555 and Alexa635 (Molecular Probes) were used
to exclude cross-hybridization and fluorescence cross-talk
when used in combination. Cells were imaged as
described earlier. The 3D reconstructions and spots
measurements were carried out using Imaris 7.2.3
software. Spots, whose centers were distant from 0 up to
0.25mm (optical resolution of the microscopic system was
estimated at 0.215 mm while images were collected), were
deemed to be co-localized. Focal adjustment of
the confocal microscope was tested using FocalCheckTM
fluorescence microscope test slide #1 (F36909,
Molecular Probes). These tests clearly showed proper
adjustment of the microscopy system (Supplementary
Figure S1).
Quantification of adenosine triphosphate (ATP)
in mitochondria
Mitochondria from cells with silenced PNPase or cells ex-
pressing hSuv3 were isolated, as described previously (28).
Adenosine triphosphate (ATP) levels in mitochondria
were analyzed using Luminescent ATP Detection Assay
Kit (ab113849, Abcam) according to the manufacturer’s
instructions.
ATP depletion and quantification
To decrease cellular ATP levels, 293 T-Rex cells were
treated with a mixture of 2-deoxy-D-glucose (10mM,
D6134, Sigma) and 50 mM carboxyatractyloside potassium
salt (C4992, Sigma) or sodium azide (3.5 or 5mM, Sigma).
Cells were collected after 2, 6, 12 and 24 h of treatment.
Cellular ATP levels were quantified using Luminescent
ATP Detection Assay Kit (ab113849, Abcam) according
to the manufacturer’s instructions.
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RESULTS
PNPase depletion stabilizes mitochondrial transcripts
Careful inspection of the human nuclear genome did not
suggest many proteins with an exoribonuclease fold and
with a putative mitochondrial targeting signal other than
PNPase. This prompted us to analyze whether PNPase
could be involved in human mtRNA decay. We checked
the effect of PNPase gene silencing on mtRNAs stability.
Four mRNAs (ND2, ND3, CytB and COX2) and one
non-coding RNA were analyzed. The mRNAs represent
transcripts that encode subunits of different complexes of
the electron transport chain and are encoded by
genes localized in different parts of the mitochondrial
genome.
We constructed a stable 293 T-Rex cell line
(293PNP_si1Res) carrying the PNPase gene with silent
mutations in the sequence complementary to an siRNA
that targets the native PNPase mRNA for destruction. In
this way, the exogenous gene expression induced by tetra-
cycline was resistant to siRNA silencing, while the native
PNPase gene expression could be silenced by the same
siRNA. Cells were transfected with control siRNA or
siRNA against PNPase. Four days post-transfection,
newly synthesized RNA was metabolically labeled by
4sU incorporation. Subsequently, RNA was isolated
from the cells, biotinylated and separated on streptavidin
beads to separate total RNA into newly synthesized and
pre-existing fractions (Figure 1A). The ratio of the
amount of pre-existing RNA to total RNA allows the
calculation of the RNA half-life (33).
Our results indicate that in cells transfected with siRNA
against PNPase and not expressing the exogenous
PNPasesi1Res gene, the half-lives of all analyzed RNAs
increased, although to different extents, compared with
cells treated with control siRNA (Figure 1B). On induc-
tion of an exogenous PNPase mutant gene resistant to
siRNA, the half-lives levels of transcripts were brought
back to the control levels (Figure 1B). As the experimental
procedure does not allow the determination of the effi-
ciency of silencing at the protein level, we checked this
in parallel experiments (see later).
Stabilization of tested mtRNAs on PNPase silencing, as
well as the fact that we reproducibly observed a pool of
PNPase resistant to proteinase K treatment in digitonin-
prepared human mitoplasts (Supplementary Figure S2),
which indicates its matrix localization, suggested that the
protein may be involved in mtRNA degradation. This
prompted us to perform further studies.
Silencing of PNPase leads to accumulation of RNA
degradation intermediates transcribed from H- and
L-strands
Previously, we showed that disruption of hSuv3 function
results in accumulation of RNA degradation intermedi-
ates (28). We expected that if PNPase is participating in
mtRNA decay, a similar phenotype should be observed.
To check this, two stable human 293 cell lines
(293PNP_si1Res and 293PNP_si2Res) containing inducible
re-coded PNPase genes resistant to siRNA silencing
were transfected with two different siRNAs against
PNPase (si1 and si2). The efficiency of endogenous
native PNPase silencing was checked by western
blotting. Transfection of cells with both si1 and si2 led
to a strong depletion of PNPase (Figure 2A). In
contrast, the level of PNPase variants resistant to silencing
was not changed (Figure 2A). To examine whether the
Figure 1. PNPase depletion stabilizes mitochondrial transcripts. (A) Schematic representation of the RNA half-life measurement, details in the text.
(B) Graph representing quantified RNA half-lives of the mitochondrial transcripts. The mean values obtained in 10 independent experiments are
presented. Error bars represent standard deviation. The P-values were obtained in an ANOVA test. Quantification of the half-life of mirror COX1 in
cells transfected with control siRNA or rescued by expression of exogenous PNPase was impossible because of its low abundance.
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potential effects on mtRNA could be due to the changes in
hSuv3 levels resulting from an off-target effect of PNPase
silencing, we tested the level of hSuv3 in PNPase-depleted
cells. Western blot analysis showed that the reduction of
PNPase expression does not change the hSuv3 levels
(Figure 2A).
Northern blot hybridization using riboprobes detecting
ND2, COX1, COX2, CytB and ND3 mRNAs revealed
that silencing of PNPase led to significant accumulation
of RNA smear, representing molecules shorter than
mature transcripts (Figures 2C and 3, Supplementary
Figure S3, left panels). A similar but far less pronounced
effect was observed in the case of a probe detecting 12S
rRNA (Supplementary Figure S3B, left panel). In
addition, inhibition of PNPase expression was found to
affect the levels of mature RNAs; this effect, however,
depends on the transcript. No substantial effect on the
levels of mature ND2 was observed (Figure 2C, left
panel), whereas the levels of ND3 increased (Supplemen-
tary Figure S3). A reduction of the steady-state level was
detected for COX1, COX2, CytB mRNAs, 12S rRNA and
tRNAs (Figure 3, Supplementary Figure S3, left panels).
Lowering of the steady-state levels of mtRNAs seems to
be in disagreement with the measured stabilization of
mt-mRNAs observed on PNPase silencing. Several
possible reasons for this are described in the discussion.
However, it is worth nothing that similar contradictory
results were observed by others for nuclear and cytoplas-
mic transcritps when the RNA-degrading machinery was
disrupted in those organelles (34–41).
Importantly, hybridization to probes detecting RNAs
complementary to the investigated RNAs, i.e. non-
coding RNAs transcribed from the opposite DNA
strand, revealed a strong accumulation of these RNA
species (Figures 2 and 3, Supplementary Figure S3,
right panels). All of these effects were abolished by
Figure 2. Silencing of PNPase leads to accumulation of mtRNA degradation intermediates. Stable cell lines (PNP_si1Res, PNP_si2Res) that express
inducible PNPase resistant to siRNA anti-PNPase or control cell line having integrated empty vector was transfected with two different siRNAs
specific for PNPase (si1 and si2) or control siRNA. Expression of exogenous PNPase was induced by tetracycline at the transfection point. Cells were
collected 4 days post-transfection and analyzed by western and northern techniques. (A) Western blot analysis of the PNPase and hSuv3 levels, as
standardization actin staining was performed. (B) Schematic representation of the polycistronic RNA resulting from H- or L-strand transcription and
localization of the used riboprobes. (C) Northern blot analysis using strand-specific riboprobes. Some hybridization signal was unspecific (especially
from cytoplasmic rRNA). This was controlled using RNA isolated from 143B rho0 (devoid of mtDNA) and their parental 143B cells. Cytosolic 18S
rRNA staining by methylene blue is shown as a loading control.
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Figure 3. PNPase depletion affects mitochondrial mRNAs. Stable cell lines (PNP_si1Res, PNP_si2Res) that express inducible PNPase resistant to
siRNA anti-PNPase or control cell line having integrated empty vector was transfected with two different siRNAs specific for PNPase (si1 and si2) or
control siRNA. Expression of exogenous PNPase was induced by tetracycline at the transfection point. Cells were collected 4 days post-transfection
and subjected to RNA isolation and northern blot analysis. Strand-specific riboprobes were used to detect mRNAs for COX1, COX2 and CytB
(A, B, and C respectively, left panels) or their antisense counterparts (A, B, and C, right panels). Some hybridization signal was unspecific (especially
from cytoplasmic rRNA). This was controlled using RNA isolated from 143B rho0 (devoid of mtDNA) and 143B cells (parent of 143B rho0).
Cytosolic 18S rRNA staining by methylene blue is shown as a loading control.
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expression of the exogenous PNPase gene resistant to
siRNA silencing (Figures 2 and 3, Supplementary Figure
S3). However, this was not the case when the catalytically
inactive PNPaseR446E (42) was expressed (Figure 4B, lanes
28 and 29 versus lanes 26 and 27). This shows that the
observed perturbations in mtRNA metabolism are
because of the lack of RNA-degrading activity of PNPase.
Noticeably, the effects of PNPase silencing on mtRNA
decay are similar to the effects of hSUV3 silencing (28).
Also, expression of the enzymatically inactive form of
PNPase leads to a dominant-negative phenotype similar
to that caused by expression of the mutated hSuv3G207V
protein (28), although the accumulation of partially
degraded RNA is not as strong (Figure 4B, lanes 11 and
12 versus lane 8).
Accumulation of transcripts on PNPase silencing, which
most likely constitute degradation intermediates and can
be removed only by active PNPase, led us to the conclu-
sion that the function performed by PNPase is required
for proper RNA decay in human mitochondria.
Interaction of PNPase with hSuv3 helicase is necessary
for mtRNA degradation
Our previous studies revealed that PNPase co-purifies
with hSuv3 and vice versa (28). In addition, in vitro
binding of both proteins was reported, and it was shown
that the deletion of five amino acids of hSuv3 (amino acids
510–514) inhibits interaction with PNPase in vitro, but it
does not affect helicase activity of hSuv3 (43).
Figure 4. Active PNPase is necessary for mitochondrial RNA degradation. Using two different siRNAs (si1 and si2), endogenous PNPase was
depleted in stable cell lines that express inducible catalytic active PNPase resistant to siRNA (PNP_si1Res and PNP_si2Res) or its inactive coun-
terpart (PNP_R446E_si1Res and PNP_R446E_si2Res). As a control, a stable cell line with integrated empty vector was used, and also, transfection
with control siRNA was performed. The 293 cell line expressing catalytically inactive hSuv3 (hSuv3_G207V) was used for a comparison with an
effect of PNPase dysfunction. Expression of inactive PNPase leads to a weak dominant-negative effect. (A) Western blot analysis of the PNPase and
hSuv3 levels. For standardization, actin staining was performed. (B) Northern blot analysis of ND2 transcript, probe detecting RNA transcribed
from both H- and L-strand of mtDNA, was used. Cytosolic 18S rRNA staining by methylene blue is shown as a loading control.
Nucleic Acids Research, 2013, Vol. 41, No. 2 1229
 at Instytut Biochem
ii i Biofizyki PA
N
 on February 12, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Exogenous overexpression of the catalytically inactive
form of hSuv3 (hSuv3G207V) has a dominant-negative
effect (28), as it probably outcompetes the endogenous
wild-type hSuv3 from its interactions with the putative
ribonucleolytic partner(s). We assumed that if PNPase
interacts with hSuv3 in vivo, the expression of inactive
hSuv3, which is in addition incapable of interacting with
PNPase, should abolish the dominant-negative pheno-
type. To verify this, we established two stable cell lines
with inducible expression of active or inactive hSuv3,
both of which lack residues 510!514 (WT/510-514
and G207V/510-514, respectively) responsible for
in vitro hSuv3–PNPase interaction. In agreement with
the data of Wang et al. (43), we found that PNPase
indeed does not co-purify with our constructed
hSuv3510514-TAP during affinity purification (see later).
RNA isolated 3 days after induction of exogenous genes
was analyzed on northern blots with probes for ND2 and
COX2. In agreement with previous results, expression of
full-length but enzymatically inert hSuv3 led to
accumulation of heterogeneous transcripts, whereas
overexpression of the wild-type hSUV3 gene had no
effect (Figure 5A). In contrast, expression of active or
inactive variants of hSuv3, both bearing the deletion abol-
ishing their interaction with PNPase, did not affect the
levels of ND2 or COX2 mRNAs nor induced the accumu-
lation of heterologous RNA (Figure 5A), although
proteins with the deletion were overexpressed to the
same extent as the full-length ones (Figure 5B). Thus,
our data suggest that in vivo interaction of PNPase with
hSuv3 is required for RNA degradation in human
mitochondria.
PNPase and hSuv3 helicase form a stable complex in vivo
Although in many cases, pull-down experiments allow the
demonstration of true interactions, this method is not
devoid of false positive results (44). Therefore, we tested
whether the interaction between PNPase and hSuv3 arises
during the purification procedure.
To do so, we mixed mitochondria isolated from cells
overexpressing hSuv3-TAP with mitochondria isolated
from cells overexpressing PNPase-FLAG. After lysis of
mitochondria, we performed affinity purification of
hSuv3-TAP and then analyzed the extracts and elutions
by western blotting with antibodies against PNPase or
FLAG tag (Figure 6A). Comparison of the amount of
detected proteins in mitochondrial lysates and purified
fractions indicated that much less FLAG-tagged PNPase
than endogenous PNPase co-purifies with hSuv3-TAP
(Figure 6B, compare lane 2 with 5 and lane 8 with 11).
This indicates that the complex of PNPase with
hSuv3-TAP had existed before mitochondria were lysed;
hence, it means that co-purification of these proteins is not
an artifact of the method.
Also, by performing parallel purification of
hSuv3510514-TAP, we show that the deletion of
residues 510–514 in hSuv3 indeed strongly inhibits inter-
action with PNPase (Figure 6B, compare lane 4 and 6).
The interaction between hSuv3 and PNPase is not
mediated by RNA because the same amount of PNPase
was purified with hSuv3-TAP regardless of the presence of
RNase A (Figure 6C). This supports interaction between
hSuv3 and PNPase in vivo.
To prove the formation of PNPase–hSuv3 complex
in vivo, we used the FLIM-FRET technique. This
method is based on a measurement of fluorescence
lifetime of FRET donor protein (in this case fusion of
PNPase with EGFP). An appearance of the energy
transfer caused by protein–protein interactions shortens
the fluorescence lifetime (45,46).
HeLa cells were transiently transfected with a plasmid
encoding PNPase-EGFP fusion protein (FRET donor) or
with a mixture of plasmids coding for PNPase-EGFP and
hSuv3-mCherry (FRET acceptor). FLIM measurements
were performed on living cells. Data analysis was cor-
rected for the instrument response function and aug-
mented by the maximum likelihood estimation
algorithm. Acquired signals were color coded according
to calculated average fluorescent lifetimes (Figure 7A).
When PNPase-EGFP fusion was expressed alone, two
fluorescent lifetimes of EGFP were calculated—1.1 and
2.7 ns (Figure 7A, left picture). Co-expression of both
proteins, PNPase-EGFP and hSuv3-mCherry, resulted in
Figure 5. Deletion of residue 510–514 of hSuv3 disables PNPase–
hSuv3 complex formation. Analysis of RNA isolated from stable 293
cell lines expressing, in an inducible manner, different forms of hSuv3
(WT: wild type, G207V: catalytically inactive, WT/510-514: wild type
with deletion of 510–514 residues and G207V/510-514: catalytically
inactive with deletion of 510-514 residues). Expression of exogenous
hSuv3 by tetracycline is indicated. Cells were collected 3 days after
induction and analyzed by northern and western blotting. (A)
Northern blot analysis of ND2 and COX2 transcripts, probes detecting
RNA transcribed from both H- and L-strand of mtDNA, were used.
The level of 7SL is shown as a loading control. (B) Western blot
analysis of the hSuv3 level. Actin staining was performed for
standardization.
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appearance of regions with significantly shorter average
fluorescent lifetime (Figure 7A, right picture, red spots),
which indicates interaction of hSuv3 and PNPase in vivo.
In most parts of the cell expressing FRET donor and
FRET acceptor, we could calculate two fluorescent life-
times (1.2 and 2.7 ns; Figure 7A, right picture, green area),
which are similar to these calculated for donor-only
sample (Figure 7A, left picture; see table for the results
of calculations). In the regions with shortened average
fluorescent lifetimes, we calculated two lifetimes—2.7
and a much shorter 0.4 ns (Figure 7A, right picture, red
area). The longer one originates from the PNPase-EGFP
donor molecules, which did not find a FRET acceptor
partner. The 0.4-ns fluorescence lifetime consists of the
quenched down long (2.7 ns) and short (1.2 ns) fluores-
cence lifetimes of the complete FRET molecules.
Altogether these results indicate that in some regions of
cells co-expressing PNPase-EGFP and hSuv3-mCherry,
the lifetime of EGFP is much decreased, which is
evidence of in vivo interaction of both proteins in these
areas. Importantly, we found that EGFP tagging does
not affect PNPase function because the wild-type fusion
protein is capable of rescuing the silencing of native
PNPase gene, but its inactive counterpart is not
(Supplementary Figure S4, Supplementary Movies S1
and S2).
Careful analysis of the FLIM results indicated that
fluorescent PNPase-EGFP molecules with shortened
fluorescence lifetime were not randomly distributed
throughout the mitochondrial network but concentrated
in distinct regions. To study this in detail, we applied the
BiFC method, as it sometimes permits higher spatial reso-
lution than FLIM-FRET. The BiFC technique enables the
investigation of proteins interaction by expressing them in
fusion with unfolded complementary fragments of a fluor-
escent reporter [in our case a variant of YFP called Venus
(47)]. If the studied proteins interact, they bring fluores-
cent protein fragments within proximity, which triggers its
reconstitution and leads to emission of a fluorescent
signal (48).
In agreement with the FLIM-FRET data, co-expression
of PNPase and hSuv3 in a fusion with the C- and
N-terminal part of Venus protein, respectively, resulted
in fluorescence complementation in mitochondria of
HeLa cells (Figure 7B and Supplementary Movies S3, S4
and S5). As presumed, the signal appeared only in spots.
Importantly, the signal emitted by the PNPase–
hSuv3510514 pair, acquired at the same excitation and
detection settings as the full-length proteins, was hardly
visible (Supplementary Figure S5A).
On the basis of the described results, we concluded that
in human mitochondria, PNPase and hSuv3 helicase form
Figure 6. Co-purification of PNPase and hSuv3 helicase is not an artifact. (A) Schematic representation of the experiment. Mitochondria from 293
cells expressing hSuv3 or PNPase in fusion with the TAP or FLAG tag, respectively, were isolated, mixed together, lysed and chromatographic
purification of hSuv3-TAP was performed. (B, C) Western blot analysis of the endogenous and exogenous PNPase levels in mitochondrial extracts
and purified fractions obtained during hSuv3-TAP purification. Specific anti-PNPase or anti-FLAG tag antibodies were used. (C) The presence of
RNase A during purification is indicated. The TAP-tagged hSuv3 protein is also detected because applied secondary antibodies produced in rabbit
(B, left panel and C) or primary antibodies produced in mouse (B, right panel) bind directly to the protein A, which is a component of TAP tag.
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a stable mtRNA-degrading complex in vivo, which we
shall call the mitochondrial degradosome.
The PNPase–hSuv3 complex is found in distinct foci
and co-localizes with mtRNA and mtDNA
Previous and current experiments showed that both en-
dogenous and exogenous expressed PNPase and hSuv3
are localized throughout the whole mitochondrial
network (20,28,29,49,50). On the contrary, experiments
using BiFC analysis clearly indicated fluorescence comple-
mentation only in well-defined distinct foci (Figure 7B).
To exclude the possibility that the observed foci are the
result of unspecific behavior of the hSuv3 or PNPase in
fusion with a part of Venus protein, we performed
immunofluorescence analysis in HeLa cells, using
anti-GFP antibodies specific to the C-terminal part of
Venus protein. This revealed that even though PNPase-
C-Venus fusion protein is present in whole mitochondria,
the fluorescence complementation appears only in foci
(Figure 8A). Expression of hSuv3-C-Venus and
hSuv3510514-C-Venus fusion proteins can also be
detected throughout mitochondria by immunofluores-
cence (Supplementary Figure S5B). However, the foci rep-
resenting the interaction between PNPase-N-Venus and
hSuv3-C-Venus are only detected when the wild-type
variant of hSuv3 is used and not the deletion mutant in-
capable of interaction with PNPase (Supplementary
Figure S5B).
These results indicate that only fractions of hSuv3 and
PNPase pools interact, and that such interactions take
place only in specific areas of mitochondria.
Interestingly, it was shown that mtRNA also localizes in
foci (51); however, their role has not been characterized
yet. Therefore, we assumed that at least some of the
mtRNA-containing foci may constitute mitochondrial
degradation bodies. To study this issue, we examined
whether the mitochondrial degradosome-containing foci
co-localize with mtRNA.
The 143B osteosarcoma cells were transfected with
plasmids enabling BiFC studies and cultured in the
presence of BrU to label RNA, which can be subsequently
detected using antibodies recognizing BrU. We also
Figure 7. PNPase and hSuv3 helicase interact in vivo. (A) FLIM-FRET analysis of PNPase expressed in fusion with EGFP and hSuv3 expressed in
fusion with mCherry. Images are color coded with respect to the average fluorescence lifetime of PNPase-EGFP. Fluorescence lifetime histograms
obtained by time-correlated single photon counting generated for defined regions of the cells are presented. Calculated lifetimes and amplitudes are
presented in the table. (B) BiFC analysis of hSuv3 and PNPase expressed in fusion with N- and C-terminal part of Venus, respectively. Mitochondria
were visualized with MitoTracker Orange. The 3D reconstructions of fluorescence images are presented. The surface of mitochondria was made
transparent to visualize PNPase–hSuv3 foci (A, B). Imaging of the living cells was performed. Bars represent 10 mm.
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visualized mitochondrial nucleoids using anti-DNA
antibodies. First, we confirmed that our experimental
procedure let us detect mtRNA and mtDNA
(Supplementary Figure S6). In agreement with previous
reports, both mtRNA and mtDNA were observed as
spots (Supplementary Figure S6). Then, we performed
object-based co-localization studies of the active and
inactive form of the mitochondrial degradosome with
mtRNA and mtDNA (Figure 8B, C and D). Such
analysis clearly showed that the hSuv3–PNPase complexes
co-localize with mtRNA and mtDNA (Figure 8B, C
and D). Four classes of the mitochondrial degradosome
could be distinguished: co-localized with mtRNA or
mtDNA, co-localized both with mtRNA and mtDNA
and a fraction of a free complex, which did not co-
localize with any detectable mitochondrial nucleic acid.
The same number of degradosome classes was observed
regardless of whether wild-type or catalytically inactive
Figure 8. The PNPase–hSuv3 complex is formed in foci and co-localizes with mtRNA and mtDNA. (A) The complex of PNPase and hSuv3 was
visualized using the BiFC technique by expression of PNPase-C-Venus and hSuv3-N-Venus fusion proteins in HeLa cells. PNPase-C-Venus was
stained using specific antibodies anti-GFP. The 3D reconstruction of fluorescence image is presented. The surface of mitochondria was made
transparent to visualize PNPase–hSuv3 foci. (B) The 3D reconstruction of PNPase–hSuv3 complexes, which were visualized by the BiFC technique,
co-localizing with mtRNA and mtDNA. RNA was stained by BrU labeling and appropriate antibodies; DNA was stained using anti-DNA
antibodies. The cross-section of the zoomed image is shown, which allows looking inside the objects. (C) Images resulting from object-based
co-localization studies performed on the image presented in B. Only co-localizing spots are shown. The threshold for co-localization was 0.25mm,
the distance between centers of the objects. (A–C) Bars represent 10 mm. (D) Graph representing the mean values of co-localization of the wild-type
and inactive (R446E/G207V) PNPase–hSuv3 complex with mtRNA or mtDNA, or both. Co-localization of mitochondrial nucleoids with mtRNA is
also shown. The P values obtained in a t-test were <0.0001 (***) or not significant (NS). The standard deviations are shown. (E) Graph representing
the total numbers of BiFC, mtRNA and mtDNA spots in cells transfected with plasmids encoding wild-type or inactive forms of PNPase (R446E)
and hSuv3 (G207V). The mean values and standard deviations are shown. The differences are statistically insignificant.
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PNPaseR446E and hSuv3G207V were analyzed (Figure 8D).
Approximately 18% of spots containing wild-type
PNPase–hSuv3 complexes co-localize exclusively with
mtRNA and 24% exclusively with mtDNA, whereas
9.5% of PNPase–hSuv3 foci co-localize both with
mtRNA and mtDNA (Figure 8D).
Expression of the degradosome complex containing
inactive proteins (PNPaseR446E and hSuv3G207V) resulted
in the increase in the number of PNPase–hSuv3 dots co-
localized only with mtRNA (30%) and the decrease of
those co-localized only with mtDNA (13%) (Figure 8D).
The amount of PNPase–hSuv3 complex co-localized with
both mtRNA and mtDNA did not change significantly.
Similarly, the fraction of mtDNA co-localized with
mtRNA, as well as the amount of a free complex, was
not altered (Figure 8D). Importantly, the differences in
co-localization results were not caused by changes in the
total numbers of spots because they stay constant regard-
less of whether the active or mutated form of PNPase–
hSuv3 complex was expressed (Figure 8E). Our results
suggest that, as in the case of cytoplasmic RNAs (5),
mtRNAs may be degraded in specific bodies. The full
composition of these bodies and their exact function
require further studies.
Silencing of PNPase leads to cell growth inhibition,
decreases the levels of mitochondrially encoded COX2
protein and reduces ATP concentration
Finally, we analyzed the effect of PNPase silencing on cell
physiology. We found that, similarly to previous studies
(29,32), depletion of PNPase leads to impaired cell
growth. To determine this, 293 cells were transfected
with control siRNA, or two different PNPase-specific
siRNAs and cells were counted during the following
days. Two days after transfection, we did not observe sig-
nificant changes in the number of cells between the control
cell culture and cultures subjected to transfection with
PNPase siRNAs (Figure 9A). A slight decrease in the
number of PNPase-depleted cells was observed 4 days
after transfection, which is concomitant with the effect
on mtRNA metabolism, and became more pronounced
later (Figure 9A). Between 6 and 8 days post-transfection
with siRNA specific for PNPase, cells stop to grow
(Figure 9A). At the same time, we did not observe
increased numbers of dead cells, which suggests that
cells stopped dividing rather than began dying.
We also investigated whether PNPase silencing alters
the levels of subunits of oxidative phosphorylation
(OXPHOS) complexes. Four days after siRNA transfec-
tion, substantial decrease in the level of mitochondrially
encoded COX2 subunit could be observed in PNPase-
depleted cells, whereas the levels of nucleus-encoded
subunits (SDHB, ATP5A and UQCRC2) were unaffected
(Figure 9B). This effect can most probably lead to dys-
function of OXPHOS. Indeed, when we conducted an
experiment in which cells were cultured for 8 days after
transfection, we observed acidification of the cell culture
medium, a hallmark of respiration defect (28,52,53) when
PNPase was down-regulated (Supplementary Figure S7).
Such an effect on PNPase silencing was also reported by
others (29) and was accompanied by changes in cell
morphology and a decrease in cell number (Sup-
plementary Figure S7). Importantly, expression of a
recoded PNPase gene, encoding wild-type PNPase but re-
sistant to the applied siRNA, reversed these phenotypes
(Supplementary Figure S7). We did not observe rescue
when catalytically inactive PNPase (R446E) was expressed
(Supplementary Figure S7).
It was previously reported that PNPase depletion
reduces the level of ATP (29,32). Moreover, it was also
found that depletion of ATP by treatment of cells with
deoxyglucose and sodium azide affects mitochondrial
polyadenylation (32). Thus, it was proposed that
PNPase indirectly influences mtRNA metabolism by
maintaining correct nucleotide concentration (32).
Therefore, we decided to see whether the changes in
mtRNA metabolism that we observe on PNPase silencing
can result from a decrease in ATP level.
First, we measured the level of ATP. In agreement with
previous studies, we found a decrease of ATP levels in
mitochondria isolated from cells with silenced PNPase in
comparison with control ones (Figure 9C). Then, we
tested whether reduction of ATP levels can lead to accu-
mulation of non-coding mtRNA and short mtRNA
species, which are characteristic for PNPase silencing.
To do so, we treated cells with chemicals affecting ATP
production by different mechanisms, including those pre-
viously applied by Slomovic and Schuster (32), and
examined their influence on mtRNA for different
periods of time. Importantly, during the course of the
treatment, which lasted 24 h, microscopy observation
revealed the cells stayed alive (data not shown). ATP
measurement confirmed a reduction of ATP in treated
cells (Figure 9D).
Subsequently, RNA isolated from control and ATP-
depleted cells was subjected to northern blot analysis
with strand-specific probes detecting ND2 mRNA or
ND2 mirror RNA. These transcripts were chosen for the
test because the ND2 mirror RNA is detectable under
normal cellular conditions. The analysis clearly showed
that ATP reduction itself does not lead to accumulation
of degradation intermediates or non-coding transcripts
(Figure 9E), which is a hallmark of PNPase silencing.
Thus, we conclude that these changes in mtRNA metab-
olism are not indirectly caused by alterations in ATP
concentration.
DISCUSSION
We demonstrate here that PNPase is the mitochondrial
RNase directly involved in mtRNA degradation. We
show that PNPase forms an RNA-degrading complex
in vivo with the helicase hSuv3. The formation of the
complex is indispensable for efficient mtRNA decay: a
catalytically inactive hSuv3 mutant has a dominant-
negative effect and inhibits mtRNA decay, but deletion
of a 5-amino acid motif involved in PNPase binding
abolishes this effect. The complex, which we have named
the mitochondrial degradosome, is formed only in distinct
foci, some of which co-localize with mtRNA spots. As the
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Figure 9. PNPase depletion impairs cell growth, mitochondrial ATP concentration and the level of COX2 protein. (A) The inhibition of cell growth
on PNPase silencing. 293 T-Rex cells were transfected with siRNA specific for PNPase or negative control siRNA. Cells were counted every 2 days
since transfection. Bars represent mean values obtained in three independent experiments; error bars represent standard deviation. (B) Western blot
analysis of OXPHOS subunits, as standardization actin staining was performed. Stable cell lines (PNP_si1Res, PNP_si2Res) that express inducible
PNPase resistant to siRNA anti-PNPase or control cell line having integrated empty vector was transfected with two different siRNAs specific for
PNPase (si1 and si2) or control siRNA. (C) Quantification of ATP levels in mitochondria after depletion of PNPase. Stable cell line that expresses
inducible PNPase resistant to siRNA anti-PNPase and control cell line having integrated empty vector were transfected with siRNA specific for
PNPase (si1) or control siRNA. Mitochondria were isolated and ATP levels were analyzed with luminometric assay. As a control, stable cell lines
expressing hSuv3 or its catalytically inactive mutant hSuv3_G207V was used. Mean values of three independent experiments are shown; error bars
represent standard deviations. (D) Quantification of ATP levels in 293 T-Rex cells treated with inhibitors of ATP synthesis. In all cases, culture media
were supplemented with 2-deoxy-D-glucose (inhibitor of glycolysis). Cells were treated with atractyloside (blocks ATP-ADP translocase) or two
indicated concentrations of sodium azide (inhibits cytochrome oxidase). Cells were collected after 2, 6, 12 and 24 h, and ATP concentrations were
analyzed by luminometric assay. Mean values from three independent measurements are presented; error bars represent standard deviations. (E)
Northern blot analysis of RNA isolated from cells described in C. Strand-specific riboprobes were used. Cytosolic 18S rRNA staining by methylene
blue is shown as a loading control.
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PNPase–hSuv3 interaction is essential for mtRNA decay
and occurs locally, it suggests that degradosome-
dependent mtRNA degradation is spatially organized.
Nonetheless, the obtained data do not rule out existence
of other PNPase/hSuv3- or degradosome-independent
mtRNA decay pathways. In particular, the human
genome encodes RNases, such as REXO2 or HRSP12,
which have been predicted or demonstrated to be
targeted to mitochondria [reviewed in (54,55)]. The role
of these proteins in mtRNA metabolism, and their poten-
tial interplay with PNPase-dependent mtRNA degrad-
ation, needs to be challenged experimentally. Thus,
although our data show that PNPase is essential for
RNA degradation in human mitochondria, it is highly
probable that there are also other RNases involved.
Inhibition of RNA degradation should result in
increased RNA stability and in the appearance of
truncated transcripts, which represent arrested degrad-
ation intermediates. Indeed, such changes indicative of
participation of PNPase in mtRNA degradation have
been observed by us in the case of cells with impaired
function of PNPase. We observed a varying impact of
PNPase inhibition on the steady-state levels of individual
transcripts tested. The mirror RNAs and other normally
low abundant non-coding RNAs accumulate strongly,
whereas mRNAs, rRNAs and tRNAs are differentially
affected. The steady-state levels of some of these RNAs
decreased. The exact mechanism responsible for this effect
remains to be elucidated. Recently, it was reported that
PNPase depletion results in the decrease of mtDNA levels
(25), which could explain the decrease in the steady-state
levels of some mature mRNAs observed by us. However,
in our experimental model, we did not see any changes in
mtDNA levels in cells with silenced PNPase
(Supplementary Figure S8), and therefore, this mechanism
cannot be responsible for the decrease of some
mt-mRNAs observed by us.
The observed decrease of some transcripts may result
from the presence of compensatory mechanism(s) or
reflect the fact that individual transcripts may be subjected
to diverse control mechanisms. In fact, human
mt-mRNAs exhibit more variability as a class than it
was previously assumed (55,56). Finally, the observed re-
duction of mtRNA levels may be a secondary effect of the
general deregulation of mitochondrial nucleic acids me-
tabolism, or it may arise from the presence of an alterna-
tive RNA decay pathway induced by accumulation of
non-coding/spurious RNA. Although it may seem to be
contradictory to the proposed role of PNPase in mtRNA
decay, such phenomena that dysfunction of RNA decay
machinery can lead to decrease of mature transcripts have
been previously observed in different cellular compart-
ments in various organisms (34–41). Similarly, decreases
in some mature mtRNAs have been observed in yeast har-
boring mutations in the SUV3 gene (2,57), which forms a
bona fide mitochondrial degradosome with the Dss1
exoribonuclease.
Our results clearly show function of the human
degradosome in mtRNA surveillance and decay. We
found that PNPase depletion has more pronounced
effects on mirror RNAs than mRNAs, which may
suggest that the complex is mainly involved in degradation
of the former. However, mirror mRNAs seems to have
high turnover, as they are hardly detectable under
normal physiological conditions. Because of the high
turnover rates, they would be especially sensitive to dys-
function of degradation machinery, so we could expect
greater effects on these RNAs after PNPase/hSuv3 inacti-
vation. Nonetheless, it may suggest that the complex may
be more involved in degradation of mirror RNAs
(removal of non-coding RNA and/or RNA surveillance)
than in mRNA decay. On the other hand, interesting data
were published recently by Chujo et al. (25). In addition to
the main subject, which is the role of LRPPRC–SLIRP
complex in mtRNA stabilization, and in line with our
data, this report includes an experiment showing that
silencing of the PNPase or hSUV3 genes leads to stabil-
ization of four tested mt-mRNAs (COX1, Cyt B, ATP6/8
and ND5), including Cyt B, which was also analyzed by
us. In contrast to the data presented here and our previous
report (28), Chujo et al. (25) show that depletion of
PNPase or hSuv3 leads to almost complete inhibition of
mitochondrial mRNA degradation; however, the effect on
the steady-state mRNA and non-coding antisense RNA
was not reported. This would indicate a crucial role of the
PNPase/hSuv3 complex in mt-mRNA decay. Discrepancy
between those data and our own regarding the intensity of
mt-mRNA stabilization cannot be easily explained. The
simplest reasons would be the different cellular models
applied (HeLa and 293 used by others and us, respect-
ively) and/or the efficiency of PNPase silencing, which
seems to be important for PNPase studies (discussed
later). Furthermore, the Suzuki group used a completely
different approach to measure stability of mt-mRNAs.
They inhibited mtRNA synthesis by treating cells with a
high concentration of ethidium bromide and then
measured the steady-state levels of mtRNAs using qPCR
(25). There are two major issues to consider here. One,
ethidium bromide treatment can affect different aspects
of the nucleic acid metabolism, for example, mtDNA rep-
lication. In our studies, we measured mt-mRNAs
half-lives without perturbation of transcription. We used
metabolic labeling of RNA with 4sU, which is not toxic
and does not affect transcription. This method is currently
considered to be the least invasive technique of RNA sta-
bility measurement (58). Second, in our approach, we used
strand specific riboprobes to detect the investigated tran-
scripts, and we found strong accumulation of antisense
transcripts on PNPase depletion; hence, experiments that
do not differentiate sense from antisense transcripts may
be misleading. Unfortunately, it is not clear whether the
others applied strand-specific qPCR in their stability
measurement experiments. Importantly, our and
Suzuki’s (25) reports are the only ones in which stability
of mtRNA after PNPase depletion were studied.
Unlike us, Chujo et al. (25) found that silencing of
PNPase causes mtDNA depletion. This could be also
related to a difference in PNPase reduction. Stronger de-
pletion of PNPase may affect mtRNA metabolism
stronger and as a consequence lead to mtDNA depletion.
This would be in line with evidence of interdependence of
RNA metabolism and DNA replication in mammalian
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mitochondria (59). Unfortunately, the effectiveness of
PNPase depletion performed by us and Chujo et al. (25)
cannot be directly compared.
Studies of PNPase localization indicated its presence in
the IMS while mtRNA is located in the mitochondrial
matrix (29). However, as pointed by Chen et al. (60),
the applied protease-protection method has a detection
limit; thus, a small amount of matrix-localized protein
may escape detection under some experimental conditions.
Indeed, our submitochondrial fractionation (Sup-
plementary Figure S2), co-purification, microscopy and
functional studies indicate that a minor fraction of
PNPase is localized in the mitochondrial matrix, where
it can form a complex with the matrix-localized hSuv3
(61). Thus, it appears that two differentially localized
pools of PNPase exist in human mitochondria. Our
data, as well as that of others (29), indicate that most of
PNPase is in the IMS; however, a smaller fraction of
PNPase, which escaped previous identification, also
exists in the matrix. Such double submitochondrial local-
ization of PNPase is in agreement with gel filtration chro-
matography analysis, which distinguished two fractions of
hSuv3, one co-migrating with and the other free of
PNPase (28). Similarly, in E. coli, only a small fraction
of PNPase was found in the degradosome (62). Moreover,
the formation of the PNPase-RhlB helicase complex, in
the absence of RNase E, has also been reported in this
organism. This interaction facilitates degradation of
dsRNA by bacterial PNPase (63). Such an auxiliary
effect was also observed for the PNPase–hSuv3 complex
in vitro (43).
Our results support the previous reported IMS localiza-
tion of a major fraction of PNPase and do not contradict
its role in RNA import into mitochondria, but they show
that the matrix-localized PNPase functions in mtRNA
degradation. Cellular tasks played by mammalian
PNPase are essential, as the knockout of the mouse
PNPase gene is embryonically lethal (30). It remains to
be determined how the partition of PNPase between the
IMS and the matrix is achieved and regulated.
Nevertheless, the results of the present and other studies
indicate that PNPase appears to play a crucial role in
controlling RNA in human mitochondria by acting at dif-
ferent levels: RNA degradation, processing and import
(30,32). It seems the RNA degradation activity of
PNPase may have substantial importance for cell physi-
ology because it can affect cellular processes by regulating
functioning of mitochondria and in addition by taking
part in turnover of specific cytoplasmic substrates, such
as mRNA for proto-oncogene c-myc and specific
miRNAs, such as miRNA-221 (64–66).
The complex of hSuv3 and PNPase exists in specific
foci, which we have named D-foci, as they contain the
degradosome complex. They can be detected using
FLIM-FRET and BiFC techniques. D-foci overlap with
mtRNA and/or mtDNA, suggesting that the degradosome
may be involved in different functions in mitochondria.
One of them is mtRNA degradation; the hypothetical
other functions, such as RNA processing and mtDNA
replication, need further studies. Co-localization of the
degradosome with mtDNA is in agreement with a report
showing the presence of hSuv3 in purified mitochondrial
nucleoids (67). Approximately half of PNPase–hSuv3-
containing foci were not co-localized with mtRNA or
mtDNA. We cannot distinguish whether the non–co-
localized D-foci do not contain RNA, or the amount of
Br-RNA is too small to be detected. Importantly, we show
that the lack of catalytic activity of both mitochondrial
degradosome components results in an increase of
complex co-localization with mtRNA. This phenomenon
is probably caused by stacking of inactive degradosome
complexes on RNA substrates.
The question arises why the function of PNPase in
human mtRNA decay was not found in silencing experi-
ments other than by Chujo et al. (25) and by us.
Apparently, depletion of PNPase in earlier analyses
resulted in contradictory results, and this subject has
been discussed in several review articles (60,64,68–70). In
some experiments, it led to changes in mitochondrial
morphology, oxygen consumption and mitochondrial
membrane potential (29), whereas in others, no such
effect was found (31). Nagaike et al. (31) showed that
silencing of PNPase caused elongation of poly(A) tails
of all tested transcripts but no changes in steady-state
levels of those transcripts were observed, while in other
studies, a reduction of PNPase had a varied impact on
different mtRNAs (32). In some studies, lack of PNPase
resulted in the decrease of mitochondrially encoded
proteins (30), whereas others did not observe any perturb-
ations in mitochondrial translation (31,32). It seems that
PNPase studies may be particularly sensitive to the degree
of its silencing, as well as the applied experimental system.
For instance, it was reported that silencing of PNPase in
293 cells reduces the levels of all examined transcripts,
such as COX1 and COX2 (30), whereas in an earlier
work using a similar experimental approach, the same
group did not observe any changes in the levels of tested
mtRNAs, including COX1 and COX2 (29). In other
studies, cell lines with a constitutively silenced PNPase
gene were used (32). Although this type of system provides
very good experimental material, its main drawback is the
possibility of compensating effects, which can mask the
primary effects. Indeed the authors observed differences
in polyadenylation of the COX1 transcript and ATP levels
between cells with stably and transiently depleted PNPase,
which was explained by the possibility of adaptation
and/or compensation mechanisms.
In our research, we used transient silencing of PNPase
by modified stealthRNAs, which in our experience gave
higher efficiency of silencing than the standard siRNAs.
Importantly, we confirmed the specificity of the observed
phenotypes by rescue experiments in which wild-type but
not catalytically inactive PNPase restored mtRNA metab-
olism. To the best of our knowledge, we are the only
group so to date to have confirmed RNAi results by
rescue experiments. We are therefore positive that the
observed phenotypes are because of PNPase depletion.
In addition, most PNPase studies concerning mtRNA
were performed using PCR-based approaches. Although
in some cases, it is indispensable (like in cRT-PCR
analysis), it does have major drawbacks. The variety of
RNA species that can be detected by a given set of PCR
Nucleic Acids Research, 2013, Vol. 41, No. 2 1237
 at Instytut Biochem
ii i Biofizyki PA
N
 on February 12, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
conditions and primers is limited. Also, the occurrence of
amplification provides no information about the length of
the template molecule because—unless special strategies
are used to avoid it—different molecules, such as precur-
sors, mature transcripts and degradation intermediates,
can give rise the same PCR product. For these reasons,
we used northern hybridizations instead of PCR in our
studies. In fact, even using a PCR-based approach,
Slomovic and Schuster found truncated transcripts in
PNPase-depleted cells, which they regarded as degradation
intermediates (32). Again, this is in line with our data.
In conclusion, we show that PNPase and hSuv3 form an
RNA-degrading complex in specific D-foci within human
mitochondria. Some of D-foci are involved in mtRNA
degradation. It remains to be elucidated what other
factors, if any, contribute to spatial organization of this
process and how mitochondrial transcripts are destined
for degradation.
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